CClinicalTrials.gg
CompletedNCT02764996Updated Apr 5, 2024Results posted

An Exploratory Prospective Trial of Rescue Acupuncture for the Treatment of Acute Migraine

An interventional study of Acupuncture in Migraine, sponsored by Mike O'Callaghan Military Hospital. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-05.

Sponsored by Mike O'Callaghan Military Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Dec 2015, registered May 2016).
Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This will be an exploratory observational trial of rescue acupuncture for the treatment of acute migraine in military beneficiaries to gain information to inform the power analysis of a larger, more definitive trial. Researchers do not seek to definitively answer the question of whether this acupuncture protocol is effective; rather, we seek to estimate the proportion of migraine episodes that result in headache-free status 20-30 minutes, 2 hours, 4 hours, and 24 hours after an acupuncture treatment. Acupuncture treatments will be subject dependent, and points could include the N point (on scalp); various auricular points to include Shen Men, Point Zero, thalamus and Omega-2; body points to include Liver 2, Liver 3, Gall Bladder 20, bladder 10; and surface release over tense areas in the neck or shoulders. Researchers will document the points used, and data will be aggregated to determine overall effectiveness. Sub-group analysis by points will be performed to determine if there is more usefulness in 1 point or combination of points. These estimates will inform statistical power calculations for a future randomized controlled trial (RCT) that directly compares the effectiveness of Rescue Acupuncture with medical management of acute migraine with rescue medication. Researchers will also assess the feasibility of this study protocol as well as patient receptivity and satisfaction.

Read the detailed description

Male and female (DoD beneficiaries). Age 18 years or older, who meet eligibility criteria will be offered an opportunity to participate via Primary Care Manager (PCM) referrals and posted advertisements will be utilized for recruiting subjects to the study. Some patients may be patients of the Principal Investigator or Associate Investigator, however, they will have the study staff recruit their patients to prevent any misconception of coercion or undue influence. When a potential subject is identified by the treating PCM, the patient will either be provide a contact number to the Research Staff, the Research Staff will be given the potential subjects contact information by the PCM, or the PCM will come and get the Research Staff to speak with the patient directly. Researchers will administer acupuncture treatments for up to 6 different migraine episodes per subject over the course of 3 months. This type of Acupuncture for this indication is routinely done as part of standard-of-care in our Family Medicine and acupuncture clinics both in conjunction with rescue medications and as a stand-alone therapy.

Screening Visit:

  • Obtain signed Informed Consent document and HIPAA Authorization. (research only)
  • Review past medical history in Armed Forces Health Longitudinal Technology Application (AHLTA) to verify the inclusion/exclusion criteria including previous encounter, vital signs review, medication list, co-morbidities, demographics, problems list, and note any prior acupuncture received. (research only)
  • Record: Date of birth, age, gender, race, ethnicity, last 4 of social security number, name of standard of care rescue medications (over-the-counter and prescription), current email address (to be used for scheduling only), height (in inches), weight (in pounds), history of traumatic brain injury, concussion, or any mild to severe head trauma, medication use, history of acupuncture. (research only)
  • Researchers will ask what the subjects expectations are regarding acupuncture's effectiveness for migraine. (research only)
  • Researchers will instruct subjects not to take their over-the-counter and prescription headache medications until after their visit with the research staff. (Standard care)
  • Researchers will instruct subjects to bring their over-the-counter and prescription headache medications with them to each visit if their symptoms do not resolve from the acupuncture treatment. (research only)
  • Patient will be instructed to contact the Research Coordinator, as soon as possible, after onset of migraine symptoms (including prodromal symptoms) to schedule an emergent visit with the research staff. (research only)
  • Patient will be given a contact card with the names and phone numbers of the research staff to contact when they have a migraine episode.

Migraine Episode:

  • Self-reported headache pain severity (0=no headache, 1=mild, 2=moderate, 3=severe) (Standard care)
  • Record type and amount of rescue medications (over-the-counter and prescription) use in the past 7 days. (research only)
  • Acupuncture treatments will be subject dependent, and points could include the N point (on scalp); various auricular points to include Shen Men, Point Zero, thalamus and Omega-2; body points to include Liver 2, Liver 3, Gall Bladder 20, bladder 10; and surface release over tense areas in the neck or shoulders. (Standard care)
  • Researchers will document the points used. (Standard care)

    *If after 20-30 minutes these patients have not had resolution of their headache, they may take their standard of care rescue medication. (research only)

  • The subject will sit for 20-30 minutes post-acupuncture(research only), and then the needles will be removed and the subject will be asked:

    o Self-reported headache pain severity (0=no headache, 1=mild, 2=moderate, 3=severe) (research only)

  • Subject is allowed to leave and will be informed of the following telephone follow ups:
  • 2 Hours post acupuncture:

    o Self-reported headache pain severity (0=no headache, 1=mild, 2=moderate, 3=severe) (research only)

  • 4 Hours post acupuncture:

    o Self-reported headache pain severity (0=no headache, 1=mild, 2=moderate, 3=severe) (research only)

  • 24 Hours post acupuncture:

    • Self-reported headache pain severity (0=no headache, 1=mild, 2=moderate, 3=severe)
    • Would you use acupuncture for future pain management? (Yes or no)
    • Would you prefer acupuncture or your rescue meds (both over-the-counter and prescription) for future episodes?
    • Record type and amount of rescue medications (over-the-counter and prescription) used since acupuncture. (research only)
02

Conditions studied

  • Migraine

Browse trials for

03

In context

Migraine Disorders

1,528 studies on the registry are indexed under Migraine Disorders; 299 are open to participants now.

This study's enrollment of 26 is below the median of 80 across 1,175 interventional studies indexed under Migraine Disorders.

Browse Migraine Disorders studies →

Lead sponsor

Mike O'Callaghan Military Hospital is the lead sponsor of 30 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients must be able to get care at Nellis Air Force Base (a military installation) in order to participate in this study.
  • Male and female DoD beneficiaries, age 18 years or older, who have been previously prescribed rescue medication to treat their acute migraine episodes.

Exclusion criteria

Exclusion:

  • Pregnant
  • Absence of ear
  • Active cellulitis of ear
  • Ear anatomy precluding identification of acupuncture landmarks
  • Use of Hearing Aids that preclude the insertion of needles
  • Use of anticoagulants
  • Unable to drive during rapid onset of migraine or inability to find someone to drive you
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
26 participants (actual)

Study arms

  • Experimental
    Acupuncture for Migraine

    Acupuncture treatments will be subject dependent, and points could include the N point (on scalp); various auricular points to include Shen Men, Point Zero, thalamus and Omega-2; body points to include Liver 2, Liver 3, Gall Bladder 20, bladder 10; and surface release over tense areas in the neck or shoulders

    Device: Acupuncture

Interventions

  • DeviceAcupuncture
06

What researchers measure

Primary outcomes

  1. Change of Migraine Headache Pain

    Change of migraine headache pain from mild, moderate or severe to pain free.

    Time frame: 24 hours post treatment.

07

Results

Posted Apr 5, 2024

Participant flow

Participant flow — Overall Study
MilestoneAcupuncture for Migraine
Started26
Completed18
Not completed8

Outcome measures

PrimaryChange of Migraine Headache Pain

Change of migraine headache pain from mild, moderate or severe to pain free.

Time frame:
24 hours post treatment.
Reported as:
Count of participants · Participants
Change of Migraine Headache Pain
ParticipantsAcupuncture for Migraine
Achieved pain free condition--yes16
achieved pain free conditon--no2

Adverse events

Collected over 24 hours. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Acupuncture for Migraine0/18 (0%)0/18 (0%)0/18 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Acupuncture for Migraine
<=18 years0
Between 18 and 65 years18
>=65 years0
Sex: Female, Male
Sex: Female, Male(Participants)Acupuncture for Migraine
Female17
Male1
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Acupuncture for Migraine
American Indian or Alaska Native0
Asian3
Native Hawaiian or Other Pacific Islander0
Black or African American2
White12
More than one race0
Unknown or Not Reported1
Region of Enrollment
Region of Enrollment(participants)Acupuncture for Migraine
United States18
08

Study locations

1 site
  • Mike O'Callaghan Federal Medical Center
    Nellis Air Force Base, Nevada 89191, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Jun 29, 2016
  • Informed consent form · Jun 29, 2016

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — Researchers are not sharing data

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02764996
Lead sponsor
Mike O'Callaghan Military Hospital
Responsible party
Sponsor
First posted
May 6, 2016
Start date
Dec 2015
Primary completion
Jun 2017
Completion
Jun 2017
Results posted
Apr 5, 2024
Last update
Apr 5, 2024

Study contacts

Sarah Bobnick, DO
principal investigator · Principal Investigator

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion